Dyne Therapeutics (DYN) Shareholder's Equity (2019 - 2026)
Dyne Therapeutics (DYN) Shareholder's Equity (2019 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Shareholder's Equity (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
7.14 Bn |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
795.79 Mn |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
595,226.00 |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
1.00 Bn |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
14.38 Mn |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
19.36 Bn |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
502.95 Mn |
| 10 |
Dyne Therapeutics |
3.00 Bn |
3.00 Bn |
- |
865.06 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
865.06 Mn |
| Dec 31, 2025 |
972.13 Mn |
| Sep 30, 2025 |
691.78 Mn |
| Jun 30, 2025 |
571.45 Mn |
| Mar 31, 2025 |
668.97 Mn |
| Dec 31, 2024 |
629.84 Mn |
| Sep 30, 2024 |
705.54 Mn |
| Jun 30, 2024 |
775.19 Mn |
| Mar 31, 2024 |
478.06 Mn |
| Dec 31, 2023 |
91.29 Mn |
| Sep 30, 2023 |
152.04 Mn |
| Jun 30, 2023 |
206.88 Mn |
| Mar 31, 2023 |
241.94 Mn |
| Dec 31, 2022 |
252.36 Mn |
| Sep 30, 2022 |
249.74 Mn |
| Jun 30, 2022 |
287.06 Mn |
| Mar 31, 2022 |
336.46 Mn |
| Dec 31, 2021 |
368.20 Mn |
| Sep 30, 2021 |
414.12 Mn |
| Jun 30, 2021 |
452.60 Mn |
